Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of British Columbia

$27,000.00

CD248 triggered insulin resistance contributes to atherosclerosis

EF 2025-26

Résumé
Atherosclerosis is the third most common cause of death worldwide and is often associated with diabetes underlying the urgent need to develop new and effective preventative and therapeutic strategies. While the main cause of atherosclerosis is unknown, it is characterized as the formation of plaques in arterial vessels from the accumulation of low-density lipoprotein (LDL), leading to the blockage of blood vessels and can result in complications such as strokes and heart attacks. Previous research has revealed that increased expression of CD248, a cell membrane protein, accelerates the progression of atherosclerosis. Additionally, patients with type 2 diabetes who have insulin resistance exhibit increased LDL levels and plaque formation. Moreover, CD248 interacts with the insulin receptor and interferes with insulin binding therefore causing insulin resistance and increased insulin levels in the blood. Despite these recent findings, there remains a gap in our understanding of the relationship between insulin, the insulin receptor, CD248, and atherosclerosis. For this research study, I hypothesize that the interaction of CD248 with the insulin receptor results in decreased LDL receptor activity and accumulation of LDL with induction in atherosclerotic plaque formation. I expect that findings of this project will provide new insights into the relationship of the CD248, insulin resistance, and LDL accumulation factors that are known to participate in atherosclerosis. The findings could help to development of new therapeutic targets for individuals with insulin resistance who are at risk of developing atherosclerosis plaques.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
575013
Name
Ghavimi Paniz
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
CD248 triggered insulin resistance contributes to atherosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Cell Biology; Diabetes; Insulin Resistance; Liver; Low Density Lipoproteins (Ldl); Metabolism; Physiology; Vascular Biology
Abstract
Atherosclerosis is the third most common cause of death worldwide and is often associated with diabetes underlying the urgent need to develop new and effective preventative and therapeutic strategies. While the main cause of atherosclerosis is unknown, it is characterized as the formation of plaques in arterial vessels from the accumulation of low-density lipoprotein (LDL), leading to the blockage of blood vessels and can result in complications such as strokes and heart attacks. Previous research has revealed that increased expression of CD248, a cell membrane protein, accelerates the progression of atherosclerosis. Additionally, patients with type 2 diabetes who have insulin resistance exhibit increased LDL levels and plaque formation. Moreover, CD248 interacts with the insulin receptor and interferes with insulin binding therefore causing insulin resistance and increased insulin levels in the blood. Despite these recent findings, there remains a gap in our understanding of the relationship between insulin, the insulin receptor, CD248, and atherosclerosis. For this research study, I hypothesize that the interaction of CD248 with the insulin receptor results in decreased LDL receptor activity and accumulation of LDL with induction in atherosclerotic plaque formation. I expect that findings of this project will provide new insights into the relationship of the CD248, insulin resistance, and LDL accumulation factors that are known to participate in atherosclerosis. The findings could help to development of new therapeutic targets for individuals with insulin resistance who are at risk of developing atherosclerosis plaques.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ghavimi, Paniz
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~